HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab

This study is ongoing, but not recruiting participants.

Study NCT00349349 Information provided by Genmab

First Received: July 6, 2006 Last Updated: July 10, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)